Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers.
Graft-versus-tumor effects can be achieved after allogeneic bone marrow transplantation in patients with malignancies of the kidney or hematopoietic system but are often accompanied by severe graft-versus-host-disease (GVHD). We sought to maximize graft-versus-tumor while minimizing GVHD using tumor-specific allogeneic effector T cells rather than open-repertoire T cells. We transferred allogeneic CD8(+) pmel-1 or CD4(+) TRP-1 T cells specific for the melanoma-associated antigens, glycoprotein 100 (gp100) and tyrosinase-related protein-1 (TRP-1), respectively, into B16-melanoma-bearing mice. Mice receiving a preparative regimen of nonmyeloablating (5 Gy) total body irradiation experienced the rapid rejection of tumor-specific allogeneic lymphocytes with no impact on tumor growth. However, when mice were given more intense total body irradiation conditioning regimens combined with autologous bone marrow transplantation, adoptively transferred allogeneic tumor-specific T lymphocytes persisted at detectable levels for several weeks and mediated significant regression of large, vascularized tumors. We found that the risk of GVHD was low when tumor-specific T cells were transferred and significant toxicity was observed only when substantial numbers of open repertoire allogeneic naive T cells were mixed with the tumor-specific lymphocytes. Taken together, these data indicate that the use of tumor-specific allogeneic CD8(+) T cells or CD4(+) can result in significant antitumor effects in the absence of measurable GVHD.
Boni
Andrea
A
Clinical Research Center, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Muranski
Pawel
P
Cassard
Lydie
L
Wrzesinski
Claudia
C
Paulos
Chrystal M
CM
Palmer
Douglas C
DC
Gattinoni
Luca
L
Hinrichs
Christian S
CS
Chan
Chi-Chao
CC
Rosenberg
Steven A
SA
Restifo
Nicholas P
NP
D019264:Adoptive Transfer / Q000379:methods*; D000818:Animals; D001787:Blood Group Incompatibility / Q000235:genetics / Q000276:immunology*; D002478:Cells, Cultured; D005260:Female; D006086:Graft vs Host Disease / Q000276:immunology / Q000517:prevention & control; D020350:Graft vs Tumor Effect / Q000235:genetics / Q000276:immunology; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology / Q000502:physiology* / Q000637:transplantation*; D008285:Major Histocompatibility Complex / Q000502:physiology*; D008546:Melanoma, Experimental / Q000276:immunology / Q000473:pathology / Q000628:therapy; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D008822:Mice, Transgenic; D012074:Remission Induction / Q000379:methods; D014184:Transplantation, Homologous / Q000276:immunology / Q000502:physiology; D047368:Tumor Burden / Q000276:immunology
J Clin Oncol. 2005 Apr 1;23(10):2346-57
15800326
J Immunother. 2005 May-Jun;28(3):258-67
15838383
Lancet. 2002 Aug 10;360(9331):436-42
12241714
Ann Surg Oncol. 1996 Jan;3(1):67-73
8770305
Immunol Cell Biol. 2008 May-Jun;86(4):312-9
18362947
Lancet Oncol. 2005 May;6(5):344-6
15863383
J Control Release. 2007 Sep 11;122(1):102-10
17628160
J Immunol. 2008 Mar 1;180(5):3122-31
18292535
J Clin Invest. 2005 Jun;115(6):1616-26
15931392
Biol Blood Marrow Transplant. 2008 May;14(5):518-30
18410894
N Engl J Med. 2000 Sep 14;343(11):750-8
10984562
Front Biosci. 2007 May 01;12:2922-34
17485269
J Exp Med. 2005 Oct 3;202(7):907-12
16203864
J Exp Med. 1998 Mar 2;187(5):693-702
9480979
Nat Biotechnol. 2008 Apr;26(4):453-61
18376399
Bone Marrow Transplant. 2002 Jul;30(2):95-102
12132048
Blood. 2004 Feb 15;103(4):1534-41
14551132
Bone Marrow Transplant. 2003 May;31(10):943-5
12748675
Blood. 1992 Jul 15;80(2):551-5
1627807
Exp Hematol. 2000 Nov;28(11):1225-31
11063870
Nat Immunol. 2004 Nov;5(11):1143-8
15475958
Nat Rev Cancer. 2008 Apr;8(4):299-308
18354418
J Clin Oncol. 2004 Oct 1;22(19):3886-92
15314059
Blood. 1995 Mar 1;85(5):1207-14
7858251
Immunol Rev. 2008 Jun;223:334-60
18613846
Blood. 2006 Sep 15;108(6):1797-808
16741253
Nat Clin Pract Oncol. 2006 Dec;3(12):668-81
17139318
Blood. 2007 Oct 15;110(8):2793-802
17638856
Hum Gene Ther. 2005 Jan;16(1):35-48
15703487
Immunol Rev. 2006 Jun;211:214-24
16824130
Cancer Immunol Immunother. 2005 Aug;54(8):721-8
16010587
Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8061-6
18523011
J Immunother. 2003 Jul-Aug;26(4):332-42
12843795
J Immunol. 2008 Jul 1;181(1):165-73
18566381
J Immunol. 1996 Dec 1;157(11):4811-21
8943383
J Immunol. 2005 Nov 15;175(10):7046-52
16272366
Lancet. 2005 Jul 23-29;366(9482):318-20
16039336
Nat Rev Immunol. 2007 Dec;7(12):942-53
18007679
Immunity. 2005 Mar;22(3):371-83
15780993
J Immunother. 2005 Jul-Aug;28(4):281-8
16000944
Curr Opin Hematol. 2007 Nov;14(6):616-24
17898565
Blood. 2008 May 15;111(10):5242-51
18285547
Cancer Immunol Immunother. 2001 Mar;50(1):3-15
11315507
Nat Rev Immunol. 2006 May;6(5):383-93
16622476
J Clin Invest. 2007 Aug;117(8):2197-204
17657310
Lancet. 1996 Aug 17;348(9025):472-3
8709796
Bone Marrow Transplant. 2005 Jun;35(12):1127-32
15834432
J Immunother. 2005 Nov-Dec;28(6):517-24
16224268
Blood. 2008 Jul 15;112(2):362-73
18354038
Blood. 2007 Jun 15;109(12):5168-77
17353346
N Engl J Med. 2003 Jan 16;348(3):255-6
12529469
J Clin Invest. 2007 Feb;117(2):492-501
17273561
Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1969-74
14762166
Bone Marrow Transplant. 2003 Feb;31(4):253-61
12621459
Nat Clin Pract Oncol. 2008 May;5(5):256-67
18398414
J Exp Med. 2003 Aug 18;198(4):569-80
12925674
Hematology Am Soc Hematol Educ Program. 2007;:460-5
18024665
Annu Rev Med. 2004;55:459-75
14746531
Gene Ther. 2007 Mar;14(6):491-502
17203106
J Clin Oncol. 2002 Apr 15;20(8):2017-24
11956260
Trends Immunol. 2008 May;29(5):235-41
18375183
J Cell Mol Med. 2009 Aug;13(8B):1962-1976
18624776
Semin Immunol. 2007 Oct;19(5):318-30
18023361
Transfusion. 2003 Dec;43(12):1667-71
14641861
Nature. 2003 Feb 20;421(6925):852-6
12594515
Pancreas. 2004 Apr;28(3):e65-9
15084986
Blood. 2007 Aug 15;110(4):1123-31
17468341
Nature. 2006 Apr 27;440(7088):1123
16641981
J Clin Invest. 2003 Jul;112(1):101-8
12840064
Science. 2003 Oct 17;302(5644):415-9
14564000
Science. 2003 Apr 11;300(5617):337-9
12690201
Blood. 2008 Apr 15;111(8):4392-402
17878399
J Exp Med. 1996 Mar 1;183(3):725-9
8642276
N Engl J Med. 2008 Jun 19;358(25):2698-703
18565862